Work

Phase II dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study Group.

Year: 1999

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: K Fujiwara, I Kohno, K Tanaka, S Ogita, Y Sasaki, K Hirabayashi, M Yakushiji, R Tsunematsu, Y Terashima, T Taguchi, Y Ohashi, K Noda

Institution: Kawasaki Medical School

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W133222613

FWCI: 0.174

Cites:

Cited by: 7

Related to: 10